The Lens Pod podcast

The Lens Newsletter November 24, 2024

27.11.2024
0:00
6:14
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Too busy to read the Lens? Listen to our weekly summary here! In this week’s episode we discuss:

  • A novel complement-inhibitor gene therapy showed reasonable safety and tolerability in a phase-one clinical trial for geographic atrophy from AMD

  • Patients with Retinitis Pigmentosa have significantly higher rates of depression compared to the general population

  • A study of Chicagoland children demonstrated increased rates of myopia progression during the COVID-19 pandemic, perhaps due to increased time spent on screens and indoors.

Flere episoder fra "The Lens Pod"